# Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance

“Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance” (2024), by Shujing Wang et al. Immunology and Microbiology research paper. Original abstract below, unchanged. A free PDF is available.

- Authors: Shujing Wang, Jingrui Wang, Zhiqiang Chen, Jiamin Luo, Wei Guo, Lingling Sun, Lizhu Lin
- Published: February 10, 2024
- Field: Immunology and Microbiology
- DOI: https://doi.org/10.1038/s41698-024-00522-z
- Free PDF: https://www.nature.com/articles/s41698-024-00522-z.pdf

## Abstract

Tumor drug resistance emerges from the interaction of two critical factors: tumor cellular heterogeneity and the immunosuppressive nature of the tumor microenvironment (TME). Tumor-associated macrophages (TAMs) constitute essential components of the TME. M2-like TAMs are essential in facilitating tumor metastasis as well as augmenting the drug resistance of tumors. This review encapsulates the mechanisms that M2-like TAMs use to promote tumor drug resistance. We also describe the emerging therapeutic strategies that are currently targeting M2-like TAMs in combination with other antitumor drugs, with some still undergoing clinical trial evaluation. Furthermore, we summarize and analyze various existing approaches for developing novel drugs that target M2-like TAMs to overcome tumor resistance, highlighting how targeting M2-like TAMs can effectively stop tumor growth, metastasis, and overcome tumor drug resistance.

Canonical page: https://nerdi.pages.dev/paper/W4391723488
Read three real papers a day in Nerdi (iPhone): https://apps.apple.com/app/apple-store/id6813826387?pt=128757794&ct=web-paper&mt=8